FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kai Kraemer

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Doreen Kunze; Daniela Wuttig; Susanne Fuessel; Kai Kraemer; Matthias Kotzsch; Axel Meye; Marc-Oliver Grimm; Oliver W Hakenberg; Manfred P Wirth
Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells.
Doreen Kunze; Daniela Wuttig; Ingo Kausch; Caroline Blietz; Lena Blumhoff; Yvonne Burmeister; Kai Kraemer; Susanne Fuessel; Marieta Toma; Bernd Schwenzer; Axel Meye; Marc-Oliver Grimm; Oliver W Hakenberg; Dieter Jocham; Manfred P Wirth
Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
Helge Taubert; T Greither; D Kaushal; Peter Würl; Matthias Bache; Frank Bartel; Astrid Kehlen; Christine Lautenschläger; L Harris; Kai Kraemer; Axel Meye; Matthias Kappler; Hannelore Schmidt; Hans-Jürgen Holzhausen; Steffen Hauptmann
Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kai Kraemer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Doreen Kunze; Daniela Wuttig; Susanne Fuessel; Kai Kraemer; Matthias Kotzsch; Axel Meye; Marc-Oliver Grimm; Oliver W Hakenberg; Manfred P Wirth
Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells.
Anticancer research 2008;28(4B):2259-63.
2008: Doreen Kunze; Daniela Wuttig; Ingo Kausch; Caroline Blietz; Lena Blumhoff; Yvonne Burmeister; Kai Kraemer; Susanne Fuessel; Marieta Toma; Bernd Schwenzer; Axel Meye; Marc-Oliver Grimm; Oliver W Hakenberg; Dieter Jocham; Manfred P Wirth
Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
International journal of oncology 2008;32(5):1049-56.
2007: Helge Taubert; T Greither; D Kaushal; Peter Würl; Matthias Bache; Frank Bartel; Astrid Kehlen; Christine Lautenschläger; L Harris; Kai Kraemer; Axel Meye; Matthias Kappler; Hannelore Schmidt; Hans-Jürgen Holzhausen; Steffen Hauptmann
Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma.
Oncogene 2007;26(7):1098-100.
2007: Susanne Fuessel; Axel Meye; Kai Kraemer; Doreen Kunze; Oliver W Hakenberg; Manfred P Wirth
Synthetic nucleic acids as potential therapeutic tools for treatment of bladder carcinoma.
European urology 2007;51(2):315-26; discussion 326-7.
2007: Kai Kraemer; Susanne Fuessel; Axel Meye
Telomerase inhibition by synthetic nucleic acids and chemosensitization in human bladder cancer cell lines.
Methods in molecular biology (Clifton, N.J.) 2007;405():9-22.
2006: Kai Kraemer; Uta Schmidt; Susanne Fuessel; Alexander Herr; Manfred P Wirth; Axel Meye
Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR.
International journal of cancer. Journal international du cancer 2006;119(6):1276-84.
2006: Susanne Fuessel; Jana Herrmann; Shuangli Ning; Matthias Kotzsch; Kai Kraemer; Uta Schmidt; Oliver W Hakenberg; Manfred P Wirth; Axel Meye
Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.
Cancer letters 2006;232(2):243-54.
2005: Uta Schmidt; Susanne Fuessel; Michael Haase; Kai Kraemer; Axel Meye; Manfred P Wirth
Quantification of C13orf19/P38IP mRNA expression by quantitative real-time PCR in patients with urological malignancies.
Cancer letters 2005;225(2):253-60.
2005: Sabine Krause; Yvonne Förster; Kai Kraemer; Susanne Fuessel; Matthias Kotzsch; Uta Schmidt; Manfred P Wirth; Axel Meye; Bernd Schwenzer
Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and Cisplatin.
The Journal of urology 2005;174(1):328-31.
2004: Kai Kraemer; Susanne Fuessel; Matthias Kotzsch; Shuangli Ning; Uta Schmidt; Manfred P Wirth; Axel Meye
Chemosensitization of bladder cancer cell lines by human telomerase reverse transcriptase antisense treatment.
The Journal of urology 2004;172(5 Pt 1):2023-8.
2004: Shuangli Ning; Susanne Fuessel; Matthias Kotzsch; Kai Kraemer; Matthias Kappler; Uta Schmidt; Helge Taubert; Manfred P Wirth; Axel Meye
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.
International journal of oncology 2004;25(4):1065-71.
2004: Uta Schmidt; Udo Bilkenroth; Clemens Linné; Susanne Fuessel; Kai Kraemer; Michael Froehner; Manfred P Wirth; Axel Meye
Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapy.
International journal of oncology 2004;24(6):1393-9.
2004: Susanne Fuessel; Bernd Kueppers; Shuangli Ning; Matthias Kotzsch; Kai Kraemer; Uta Schmidt; Axel Meye; Manfred P Wirth
Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cells.
The Journal of urology 2004;171(6 Pt 1):2471-6.
2003: Kai Kraemer; Susanne Fuessel; Uta Schmidt; Matthias Kotzsch; Bernd Schwenzer; Manfred P Wirth; Axel Meye
Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 1):3794-800.